Sep 29

QP 25 - Clinical Potpourri: Navigating Early-Stage RT, N1mi Disease, and Risk Mitigation in Triple Negative and HER2+ Breast Cancer

1150 - Dosimetric Predictors of Pneumonitis In Patients with Localized HER2-Positive Breast Cancer Receiving Radiotherapy and Trastuzumab-Emtansine

05:30pm - 05:35pm ET

Presenter(s)

Hannah Bacon, MD, PhD - University of Toronto, Toronto, ON